BACKGROUND AND PURPOSE: Although radiation induced reoxygenation has been thought to increase radiosensitivity, we have shown that its associated oxidative stress can have radioprotective effects, including stabilization of the transcription factor hypoxia inducible factor 1 (HIF-1). HIF-1 is known to regulate many of the glycolytic enzymes, thereby promoting aerobic glycolysis, which is known to promote treatment resistance. Thus, we hypothesized that reoxygenation after radiation would increase glycolysis. We previously showed that blockade of oxidative stress using a superoxide dismutase (SOD) mimic during reoxygenation can downregulate HIF-1 activity. Here we tested whether concurrent use of this drug with radiotherapy would reduce the switch to a glycolytic phenotype. MATERIALS AND METHODS: 40 mice with skin fold window chambers implanted with 4T1 mammary carcinomas were randomized into (1) no treatment, (2) radiation alone, (3) SOD mimic alone, and (4) SOD mimic with concurrent radiation. All mice were imaged on the ninth day following tumor implantation (30 h following radiation treatment) following injection of a fluorescent glucose analog, 2-[N-(7-nitrobenz-2-oxa-1,3-diaxol-4-yl)amino]-2-deoxyglucose (2-NBDG). Hemoglobin saturation was measured by using hyperspectral imaging to quantify oxygenation state. RESULTS: Mice treated with radiation showed significantly higher 2-NBDG fluorescence compared to controls (p=0.007). Hemoglobin saturation analysis demonstrated reoxygenation following radiation, coinciding with the observed increase in glycolysis. The concurrent use of the SOD mimic with radiation demonstrated a significant reduction in 2-NBDG fluorescence compared to effects seen after radiation alone, while having no effect on reoxygenation. CONCLUSIONS: Radiation induces an increase in tumor glucose demand approximately 30 h following therapy during reoxygenation. The use of an SOD mimic can prevent the increase in aerobic glycolysis when used concurrently with radiation, without preventing reoxygenation.
BACKGROUND AND PURPOSE: Although radiation induced reoxygenation has been thought to increase radiosensitivity, we have shown that its associated oxidative stress can have radioprotective effects, including stabilization of the transcription factor hypoxia inducible factor 1 (HIF-1). HIF-1 is known to regulate many of the glycolytic enzymes, thereby promoting aerobic glycolysis, which is known to promote treatment resistance. Thus, we hypothesized that reoxygenation after radiation would increase glycolysis. We previously showed that blockade of oxidative stress using a superoxide dismutase (SOD) mimic during reoxygenation can downregulate HIF-1 activity. Here we tested whether concurrent use of this drug with radiotherapy would reduce the switch to a glycolytic phenotype. MATERIALS AND METHODS: 40 mice with skin fold window chambers implanted with 4T1 mammary carcinomas were randomized into (1) no treatment, (2) radiation alone, (3) SOD mimic alone, and (4) SOD mimic with concurrent radiation. All mice were imaged on the ninth day following tumor implantation (30 h following radiation treatment) following injection of a fluorescent glucose analog, 2-[N-(7-nitrobenz-2-oxa-1,3-diaxol-4-yl)amino]-2-deoxyglucose (2-NBDG). Hemoglobin saturation was measured by using hyperspectral imaging to quantify oxygenation state. RESULTS:Mice treated with radiation showed significantly higher 2-NBDG fluorescence compared to controls (p=0.007). Hemoglobin saturation analysis demonstrated reoxygenation following radiation, coinciding with the observed increase in glycolysis. The concurrent use of the SOD mimic with radiation demonstrated a significant reduction in 2-NBDG fluorescence compared to effects seen after radiation alone, while having no effect on reoxygenation. CONCLUSIONS: Radiation induces an increase in tumor glucose demand approximately 30 h following therapy during reoxygenation. The use of an SOD mimic can prevent the increase in aerobic glycolysis when used concurrently with radiation, without preventing reoxygenation.
Authors: Gregory M Palmer; Andrew N Fontanella; Siqing Shan; Gabi Hanna; Guoqing Zhang; Cassandra L Fraser; Mark W Dewhirst Journal: Nat Protoc Date: 2011-08-18 Impact factor: 13.491
Authors: Yiting Cao; Chuan-Yuan Li; Benjamin J Moeller; Daohai Yu; Yulin Zhao; Matthew R Dreher; Siqing Shan; Mark W Dewhirst Journal: Cancer Res Date: 2005-07-01 Impact factor: 12.701
Authors: Zrinka Rajic; Artak Tovmasyan; Ivan Spasojevic; Huaxin Sheng; Miaomiao Lu; Alice M Li; Edith B Gralla; David S Warner; Ludmil Benov; Ines Batinic-Haberle Journal: Free Radic Biol Med Date: 2012-02-13 Impact factor: 7.376
Authors: Sean P Pitroda; Bassam T Wakim; Ravi F Sood; Mara G Beveridge; Michael A Beckett; Dhara M MacDermed; Ralph R Weichselbaum; Nikolai N Khodarev Journal: BMC Med Date: 2009-11-05 Impact factor: 8.775
Authors: Nimmi Ramanujam; Mark W Dewhirst; Fangyao Hu; Karthik Vishwanath; Joseph K Salama; Alaattin Erkanli; Bercedis Peterson; James R Oleson; Walter T Lee; David M Brizel Journal: Int J Radiat Oncol Biol Phys Date: 2016-06-14 Impact factor: 7.038
Authors: Jacqueline P Williams; Laura Calvi; Joe V Chakkalakal; Jacob N Finkelstein; M Kerry O'Banion; Edward Puzas Journal: Radiat Res Date: 2016-06-22 Impact factor: 2.841
Authors: Narasimhan Rajaram; Amy E Frees; Andrew N Fontanella; Jim Zhong; Katherine Hansen; Mark W Dewhirst; Nirmala Ramanujam Journal: PLoS One Date: 2013-10-18 Impact factor: 3.240
Authors: Martina Schuster; Gargi Tewary; Xuanwen Bao; Prabal Subedi; Stefanie M Hauck; Ann Karin Olsen; Dag Markus Eide; Klaus Rüdiger Trott; Sebastian Götz; Michael J Atkinson; Michael Rosemann Journal: Radiat Environ Biophys Date: 2021-07-21 Impact factor: 1.925